Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Clearside Biomedical News

    1,31 $ +3,97% +0,05 $
    In : 1,2239 € | 20:39:32 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2ALP6
    ISIN: US1850631045
    US-Symbol: CLSD
    Typ: Aktie

    Clearside Biomedical News

    13.03.24 - PR Newswire
    Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?
    Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences? PR Newswire
    17.11.22 - PR Newswire
    Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical?
    Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire
    10.11.22 - PR Newswire
    Thinking about buying stock in Digital Turbine, Purple Innovation, Clearside Biomedical, Rivian Automotive, or ZipRecruiter?
    Thinking about buying stock in Digital Turbine, Purple Innovation, Clearside Biomedical, Rivian Automotive, or ZipRecruiter? PR Newswire
    28.03.22 - PR Newswire
    Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners?
    Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners? PR Newswire
    11.03.22 - PR Newswire
    Thinking about buying stock in Clearside Biomedical, Pearson, Paramount Gold Nevada, Hycroft Mining, or Alto Ingredients?
    Thinking about buying stock in Clearside Biomedical, Pearson, Paramount Gold Nevada, Hycroft Mining, or Alto Ingredients? PR Newswire
    25.10.21 - PR Newswire
    Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
    Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular ...
    15.08.21 - PR Newswire
    Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India
    Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India PR Newswire
    25.06.21 - PR Newswire
    Thinking about buying stock in Osmotica Pharmaceuticals, Property Solutions Acquisition, Sio Gene Therapies, Clearside Biomedical, or Sorrento Therapeutics?
    Thinking about buying stock in Osmotica Pharmaceuticals, Property Solutions Acquisition, Sio Gene Therapies, Clearside Biomedical, or Sorrento Therapeutics? PR Newswire
    17.06.21 - PR Newswire
    Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals?
    Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals? PR Newswire
    15.06.21 - PR Newswire
    Thinking about buying stock in Clearside Biomedical, Uxin, Petco Health and Wellness, Ashford Hospitality Trust, or Uber?
    Thinking about buying stock in Clearside Biomedical, Uxin, Petco Health and Wellness, Ashford Hospitality Trust, or Uber? PR Newswire
    02.06.21 - PR Newswire
    Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
    Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) PR Newswire
    08.01.21 - PR Newswire
    Thinking about buying stock in Capricor Therapeutics, Cardtronics, Clearside Biomedical, Ardelyx, or FuelCell Energy?
    Thinking about buying stock in Capricor Therapeutics, Cardtronics, Clearside Biomedical, Ardelyx, or FuelCell Energy? PR Newswire
    05.01.21 - PR Newswire
    Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology?
    Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology? PR Newswire
    04.01.21 - PR Newswire
    Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray?
    Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray? PR Newswire
    28.01.20 - PR Newswire
    Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
    Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in ...
    17.12.19 - sharedeals.de
    Clearside Biomedical: NBC-Aktie mit +307% in drei Monaten
    Mit der Aktie von Clearside Biomedical (WKN: A2ALP6) nutzten NBC-​Mitglieder bereits Anfang des Jahres ordentliche Kurs­gewinne zum Ausstieg. Nach einer erneuten Empfehlung ...
    17.12.19 - Finanztrends
    Clearside Biomedical: NBC-Aktie mit +307% in drei Monaten
    Mit der Aktie von Clearside Biomedical (WKN: A2ALP6) nutzten NBC-​Mitglieder bereits Anfang des Jahres ordentliche Kurs­gewinne zum Ausstieg. Nach einer erneuten Empfehlung ...
    23.10.19 - PR Newswire
    Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
    Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema ...
    04.09.19 - PR Newswire
    REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
    REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314 - REGENXBIO ...
    21.02.19 - PR Newswire
    Thinking about buying stock in ARCA biopharma, Clearside Biomedical, Kandi Technologies, Nike or Tahoe Resources?
    Thinking about buying stock in ARCA biopharma, Clearside Biomedical, Kandi Technologies, Nike or Tahoe Resources? PR Newswire

    Newssuche

    Videos

    08:40 Uhr +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »